![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
LA Marshall, JD Winkler, DE Griswold, B Bolognese, A Roshak, CM Sung, EF Webb and R Jacobs
Department of Inflammation and Respiratory Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania.
The role of scalaradial (SLD) (or its 12-epi analog), a marine natural product purified from sponge (Cacospongia mollior) in human neutrophil (polymorphonuclear leukocyte, PMN) arachidonic acid metabolism was studied. SLD potently inhibited human recombinant (rh) type II-14 kDa- phospholipase A2 (PLA2) (IC50 = 0.07 microM) but displayed weak inhibition of U937 cell, 85 kDa-PLA2 (IC50 = 20 microM). Sn-2 acylhydrolytic activity expressed in human PMN acid extract, that was completely neutralized by anti-rh type II-14 kDa-PLA2 monoclonal antibody, was inhibited by SLD in a concentration-dependent manner (IC50 = 35 microM). Exposure of human PMN to SLD resulted in a concentration-dependent inhibition of calcium ionophore (A23187)- induced leukotriene B4 release (IC50 = 0.1-0.6 microM). In contrast to the action of selective 5-lipoxygenase inhibitors (WY 50295 or zileuton), SLD decreased A23187-induced PMN liberation of arachidonic acid mass and platelet-activating factor biosynthesis (IC50 = 1-2 microM). PMN acetyltransferase activity was not significantly affected by SLD suggesting that platelet-activating factor inhibition was due, predominantly, to inactivation of PLA2 activity. In vivo, topical application of SLD on mouse ear treated with phorbol ester, not only inhibited edema formation but also the increase in myeloperoxidase activity (an index of cellular infiltration). SLD had little or no effect on arachidonic acid-induced ear edema or myeloperoxidase which is consistent with an action on PLA2. Take together these data suggest that the predominant mechanism of SLD is via inhibition of 14 kDa-like- PLA2 and suggests that this enzyme may participate in PMN arachidonic acid liberation and lipid mediator formation.
This article has been cited by other articles:
|
|
 |
|
  J. Pindado, J. Balsinde, and M. A. Balboa TLR3-Dependent Induction of Nitric Oxide Synthase in RAW 264.7 Macrophage-Like Cells via a Cytosolic Phospholipase A2/Cyclooxygenase-2 Pathway J. Immunol., October 1, 2007; 179(7): 4821 - 4828. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Ruiperez, J. Casas, M. A. Balboa, and J. Balsinde Group V Phospholipase A2-Derived Lysophosphatidylcholine Mediates Cyclooxygenase-2 Induction in Lipopolysaccharide-Stimulated Macrophages J. Immunol., July 1, 2007; 179(1): 631 - 638. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Maeda, Y.-i. Ozaki, S. Sivakumaran, T. Akiyama, H. Urakubo, A. Usami, M. Sato, K. Kaibuchi, and S. Kuroda Ca-independent phospholipase A2-dependent sustained Rho-kinase activation exhibits all-or-none response. Genes Cells, September 1, 2006; 11(9): 1071 - 1083. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Petry, A. Huwiler, W. Eberhardt, M. Kaszkin, and J. Pfeilschifter Hypoxia Increases Group IIA Phospholipase A2 Expression under Inflammatory Conditions in Rat Renal Mesangial Cells J. Am. Soc. Nephrol., October 1, 2005; 16(10): 2897 - 2905. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Xie, L. Liu, X. Huang, Y. Guo, and L. Lou Scalaradial Inhibition of Epidermal Growth Factor Receptor-Mediated Akt Phosphorylation Is Independent of Secretory Phospholipase A2 J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1210 - 1217. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Krimsky, S. Yedgar, L. Aptekar, O. Schwob, G. Goshen, A. Gruzman, S. Sasson, and M. Ligumsky Amelioration of TNBS-induced colon inflammation in rats by phospholipase A2 inhibitor Am J Physiol Gastrointest Liver Physiol, August 8, 2003; 285(3): G586 - G592. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Marshall, E. Krump, T. Lindsay, G. Downey, D. A. Ford, P. Zhu, P. Walker, and B. Rubin Involvement of Cytosolic Phospholipase A2 and Secretory Phospholipase A2 in Arachidonic Acid Release from Human Neutrophils J. Immunol., February 15, 2000; 164(4): 2084 - 2091. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Crocker, N. Lawson, I. Daniels, P. Baker, and J. Fletcher Significance of Fatty Acids in Pregnancy-Induced Immunosuppression Clin. Vaccine Immunol., July 1, 1999; 6(4): 587 - 593. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Surette, N. Dallaire, N. Jean, S. Picard, and P. Borgeat Mechanisms of the priming effect of lipopolysaccharides on the biosynthesis of leukotriene B4 in chemotactic peptide-stimulated human neutrophils FASEB J, November 1, 1998; 12(14): 1521 - 1531. [Abstract] [Full Text]
|
|
|
|
|
|
L. Thommesen, W. Sjursen, K. Gasvik, W. Hanssen, O.-L. Brekke, L. Skattebol, A. K. Holmeide, T. Espevik, B. Johansen, and A. Lagreid Selective Inhibitors of Cytosolic or Secretory Phospholipase A2 Block TNF-Induced Activation of Transcription Factor Nuclear Factor-{kappa}B and Expression of ICAM-1 J. Immunol., October 1, 1998; 161(7): 3421 - 3430. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Daniels, M. A. Lindsay, C. I. C. Keany, R. P. Burden, J. Fletcher, and A. P. Haynes Role of Arachidonic Acid and Its Metabolites in the Priming of NADPH Oxidase in Human Polymorphonuclear Leukocytes by Peritoneal Dialysis Effluent Clin. Vaccine Immunol., September 1, 1998; 5(5): 683 - 689. [Abstract] [Full Text]
|
|
|
|
|
|
T. R. Hundley, L. A. Marshall, W. C. Hubbard, and D. W. Macglashan Jr. Characteristics of Arachidonic Acid Generation in Human Basophils: Relationship Between the Effects of Inhibitors of Secretory Phospholipase A2 Activity and Leukotriene C4 Release J. Pharmacol. Exp. Ther., March 1, 1998; 284(3): 847 - 857. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. D. Winkler, C.-M. Sung, M. Chabot-Flecher, D. E. Griswold, L. A. Marshall, F. H. Chilton, W. Bondinell, and R. J. Mayer beta -Lactams SB 212047 and SB 216754 Are Irreversible, Time-Dependent Inhibitors of Coenzyme A-Independent Transacylase Mol. Pharmacol., February 1, 1998; 53(2): 322 - 329. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. M. Anderson, A. Roshak, J. D. Winkler, M. McCord, and L. A. Marshall Cytosolic 85-kDa Phospholipase A2-mediated Release of Arachidonic Acid Is Critical for Proliferation of Vascular Smooth Muscle Cells J. Biol. Chem., November 28, 1997; 272(48): 30504 - 30511. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Escrig, A. Ubeda, M. L. Ferrandiz, J. Darias, J. M. Sanchez, M. J. Alcaraz, and M. Paya Variabilin: A Dual Inhibitor of Human Secretory and Cytosolic Phospholipase A2 With Anti-inflammatory Activity J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 123 - 131. [Abstract] [Full Text]
|
|
|
|
|
|
C. O. Bingham III, M. Murakami, H. Fujishima, J. E. Hunt, K. F. Austen, and J. P. Arm A Heparin-sensitive Phospholipase A2 and Prostaglandin Endoperoxide Synthase-2 Are Functionally Linked in the Delayed Phase of Prostaglandin D2 Generation in Mouse Bone Marrow-derived Mast Cells J. Biol. Chem., October 18, 1996; 271(42): 25936 - 25944. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. K. Roshak, E. A. Capper, C. Stevenson, C. Eichman, and L. A. Marshall Human Calcium-independent Phospholipase A2 Mediates Lymphocyte Proliferation J. Biol. Chem., November 10, 2000; 275(46): 35692 - 35698. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
